Withdrawal of Immunomodulators or TNF Antagonists in Patients With Inflammatory Bowel Diseases in Remission on Combination Therapy: A Systematic Review and Meta-analysis-Reference-Cited by-同舟云学术

Withdrawal of Immunomodulators or TNF Antagonists in Patients With Inflammatory Bowel Diseases in Remission on Combination Therapy: A Systematic Review and Meta-analysis

Published:2024-01 Issue:1 Volume:22 Page:22-33.e6
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Katibian David J.,Solitano Virginia,Polk D. Brent,Nguyen Tran,Ma Christopher,Syal Gaurav,Kobayashi Taku,Hibi Toshifumi,Buhl Sine,Ainsworth Mark Andrew,Jairath Vipul,Singh Siddharth^ORCID

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

National Institutes of Health

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference46 articles.

1. AGA Clinical Practice Guidelines on the medical management of moderate to severe luminal and perianal fistulizing Crohn’s disease;Feuerstein;Gastroenterology,2021

2. ACG Clinical Guideline: management of Crohn’s disease in adults;Lichtenstein;Am J Gastroenterol,2018

3. ECCO Guidelines on therapeutics in Crohn’s disease: medical treatment;Torres;J Crohns Colitis,2020

4. SONIC Study Group Infliximab, azathioprine, or combination therapy for Crohn’s disease;Colombel;N Engl J Med,2010

5. Upfront combination therapy, compared with monotherapy, for patients not previously treated with a biologic agent associates with reduced risk of inflammatory bowel disease-related complications in a population-based cohort study;Targownik;Clin Gastroenterol Hepatol,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Focusing on non-responders to infliximab with ulcerative colitis, what can we do first and next?;International Immunopharmacology;2024-11

2. Clinical impacts of immunomodulator withdrawal from anti‐tumor necrosis factor combination therapy in pediatric inflammatory bowel disease;Journal of Pediatric Gastroenterology and Nutrition;2024-07

3. Unmet needs of drugs for irritable bowel syndrome and inflammatory bowel diseases: interest of vagus nerve stimulation and hypnosis;Inflammopharmacology;2024-03-21

4. Focusing on Non-Responders to Infliximab with Ulcerative Colitis, What Can We Do First and Next?;2024